Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Journey Medical Corporation (DERM) had Revenue of $56.13M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$56.13M
Net Income	$-14.67M
Cost of Goods Sold	$20.88M
Gross Profit	$35.26M
Operating Expenses	$69.81M
Operating Income	$-13.68M
Non-Operating Income/Expense	$-0.93M
Pre-Tax Income	$-14.61M
Normalized Pre-Tax Income	$-14.61M
Income after Taxes	$-14.67M
Income from Continuous Operations	$-14.67M
Consolidated Net Income/Loss	$-14.67M
Normalized Income after Taxes	$-14.67M
EBIT	$-13.68M
EBITDA	$-9.95M
Weighted-Average Shares Outstanding (Basic)	20.43M
Weighted-Average Shares Outstanding (Diluted)	20.43M
Earnings per Share (EPS) (Basic)	$-0.72
Earnings per Share (EPS) (Diluted)	$-0.72
Balance Sheet Financials
Current Assets	$48.18M
Property, Plant, and Equipment	--
Long-Term Assets	$32.06M
Total Assets	$80.24M
Current Liabilities	$35.17M
Long-Term Debt	$24.88M
Long-Term Liabilities	$25.00M
Total Liabilities	$60.17M
Common Equity	$20.07M
Tangible Shareholders Equity	$-11.79M
Shareholders Equity	$20.07M
Common Shares Outstanding	22.15M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-9.13M
Cash Flow from Investing Activities	$-15.00M
Cash Flow from Financial Activities	$16.99M
Beginning Cash	$27.44M
End Cash	$20.30M
Increase/Decrease in Cash	$-7.13M
Stock-Based Compensation	$6.10M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.37
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.55
Debt to Equity Ratio	1.24
Gross Margin	62.81%
Operating Margin	-24.36%
EBIT Margin	-24.36%
EBITDA Margin	-17.72%
Pre-Tax Profit Margin	-26.03%
Profit Margin	-26.14%
Free Cash Flow	$-9.13M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.70
Inventory Turnover	1.45
Receiveable Turnover	5.49
Days Sales in Receivables	66.53
Return on Equity	-73.11%
Return on Tangible Equity	124.40%
Return on Assets	-18.28%
Return on Investments	-32.64%
Book Value Per Share	$0.91
Free Cash Flow per Share	$-0.45
Operating Cash Flow per Share	$-0.45

Data from Zacks Investment Research, Inc.